Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7278
Rank
โ‚น53.84 B
Marketcap
โ‚น1,538
Share price
-0.33%
Change (1 day)
-42.73%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚น16.13 Billion

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total assets are โ‚น16.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avalon Pharma (Middle East Pharmaceutical) - Total assets on balance sheet (from 2023 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚น14.35 B19.22%
2024-12-31โ‚น12.04 B19.69%
2023-12-31โ‚น10.06 B